1. Project snapshot
Trials Matcher is an AI‑powered portal that helps patients, investigators and sponsors locate recruiting clinical studies worldwide. Smart filters (condition, location, age, phase, etc.) and an intuitive search flow replace the clutter of multiple government registries with a single, user‑friendly interface.
2. Goals & success metrics
- Accelerate recruitment by matching the right participants to the right trials faster.
- Streamline stakeholder workflows—sites, CROs and sponsors collaborate in one hub.
- KPIs: time‑to‑first‑patient‑in, enrolment velocity, user retention, study‑page conversions.
3. Core problem
Fragmented data sources and outdated registries make it hard for patients to discover trials and for sponsors to fill cohorts, causing costly delays in life‑saving research.
4. Solution highlights
- AI‑driven keyword and semantic search.
- Rich, faceted filters (phase, location, sponsor, gender, etc.).
- Real‑time study cards showing status, site addresses and NCT IDs.
- Central dashboard for sponsors/CROs to monitor enrolment and retention.
5. Experience flow
- Find a study via search or curated disease lists.
- Check high‑level eligibility criteria.
- Contact the study team if pre‑qualified.
- Track application status in a personal dashboard.
6. Trials Matcher by the numbers
- 5000 + biopharma & CRO clients.
- 3 400 + institutions and academic medical centers.
- 300 000 + global research sites; 250 000 + investigators.
- 95 % of 2022 FDA‑approved therapeutics supported.
- 4 000 + trials in 130 + countries in the past year.
- 55 + years of leadership in ethical review.
7. Values & differentiators
- Client‑centricity, integrity, collaboration and DEI focus.
- 55 years of expertise distilled into actionable data intelligence.
- Seamless connection of sponsors, CROs, sites and participants.
8. Outcome & next steps
Trials Matcher is poised to cut enrolment timelines and improve data quality across thousands of active studies. Upcoming releases will add eConsent, multilingual accessibility and deeper analytics for sponsor ROI.